817 related articles for article (PubMed ID: 9810002)
1. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
2. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
[TBL] [Abstract][Full Text] [Related]
3. Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site.
Wolf J; Jox A; Skarbek H; Pukrop T; Bartnitzke S; Pawlita M; Diehl V; Bullerdiek J
Virology; 1995 Sep; 212(1):179-85. PubMed ID: 7676627
[TBL] [Abstract][Full Text] [Related]
4. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells.
Hu LF; Chen F; Altiok E; Winberg G; Klein G; Ernberg I
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():248-60. PubMed ID: 10895161
[TBL] [Abstract][Full Text] [Related]
5. The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.
Steel CM; Morten JE; Foster E
IARC Sci Publ; 1985; (60):265-92. PubMed ID: 2998993
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cells.
Wolf J; Draube A; Bohlen H; Jox A; Mücke S; Pawlita M; Möller P; Diehl V
Int J Cancer; 1995 Feb; 60(4):527-33. PubMed ID: 7829268
[TBL] [Abstract][Full Text] [Related]
7. [Invasive, metastatic growth of lymphoblastoid B cells in immunodeficient SCID mice].
Walter J; Wolf J; Pawlita M; Schirrmacher V; Moldenhauer G; Möller P
Verh Dtsch Ges Pathol; 1991; 75():224-8. PubMed ID: 1724838
[TBL] [Abstract][Full Text] [Related]
8. Regressing nude mouse grafts of Burkitt's lymphoma x lymphoblastoid cell hybrids show deregulation of the c-myc gene and expression of the EBV latent membrane protein.
Wolf J; Klevenz B; Pawlita M; Komitowski D; Moldenhauer G; zur Hausen H
Int J Cancer; 1991 Jan; 47(1):99-104. PubMed ID: 1702406
[TBL] [Abstract][Full Text] [Related]
9. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice.
Walter J; Möller P; Moldenhauer G; Schirrmacher V; Pawlita M; Wolf J
Int J Cancer; 1992 Jan; 50(2):265-73. PubMed ID: 1309726
[TBL] [Abstract][Full Text] [Related]
10. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
Benedict WF; Weissman BE; Mark C; Stanbridge EJ
Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
[TBL] [Abstract][Full Text] [Related]
11. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
[TBL] [Abstract][Full Text] [Related]
12. Regulation of germ-line epsilon transcription and induction of epsilon switching in cloned EBV-transformed and malignant human B cell lines by cytokines and CD4+ T cells.
Gauchat JF; Gascan H; de Waal Malefyt R; de Vries JE
J Immunol; 1992 Apr; 148(7):2291-9. PubMed ID: 1347554
[TBL] [Abstract][Full Text] [Related]
13. Reversion of tumorigenicity in an EBV-converted Burkitt's lymphoma line.
Klein G
Ciba Found Symp; 1989; 142():36-48; discussion 48-53. PubMed ID: 2545422
[TBL] [Abstract][Full Text] [Related]
14. Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage.
Schäfer R; Hoffmann H; Willecke K
Cancer Res; 1983 May; 43(5):2240-6. PubMed ID: 6831446
[TBL] [Abstract][Full Text] [Related]
15. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines.
Röth A; Pfaff P; Lange W; Finke J
Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686
[TBL] [Abstract][Full Text] [Related]
16. Accessory function of human leukemic cell lines: properties of B and B-K562 hybrid cell lines.
Wakasugi H; Dokhelar MC; Garson D; Harel-Bellan A; Fradelizi D; Tursz T
Eur J Immunol; 1985 Mar; 15(3):256-61. PubMed ID: 3872216
[TBL] [Abstract][Full Text] [Related]
17. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.
Klinger HP; Shows TB
J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230
[TBL] [Abstract][Full Text] [Related]
18. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
19. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).
Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R
J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of an in vitro model system for human papillomavirus type 16-associated tumorigenesis.
Seagon S; Dürst M
Cancer Res; 1994 Nov; 54(21):5593-8. PubMed ID: 7923202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]